{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:02:11Z","timestamp":1772748131528,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","funder":[{"name":"Isotopes and Drugs National Engineering Research Center Isotopes and Drugs Innovation Fund","award":["TWSCX-2023-CXJJ-3-1"],"award-info":[{"award-number":["TWSCX-2023-CXJJ-3-1"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    Sclerosing epithelioid fibrosarcoma is extremely rare and aggressive soft-tissue sarcoma. Here, we report the\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTA-IBA PET\/CT findings in a case with sclerosing epithelioid fibrosarcoma with bone metastases.\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTA-IBA PET\/CT revealed increased uptake of DOTA-IBA in bone metastases. Unexpectedly,\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTA-IBA uptake was also observed in the primary sclerosing epithelioid fibrosarcoma in the abdomen.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006315","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T21:01:00Z","timestamp":1772485260000},"page":"341-342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Increased Uptake of 68Ga-DOTA-IBA in Sclerosing Epithelioid Fibrosarcoma"],"prefix":"10.1097","volume":"51","author":[{"given":"Miao","family":"Liu","sequence":"first","affiliation":[{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou"},{"name":"Department of Nuclear Medicine, Ya\u2019an People\u2019s Hospital, Ya\u2019an"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Liu","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou"},{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation, Luzhou, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou"},{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation, Luzhou, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanwen","family":"Huang","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou"},{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation, Luzhou, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-7649","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou"},{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Laboratory for Targeted Radiopharmaceuticals Creation, Luzhou, Sichuan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"R1-20260305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/PAS.0000000000001559","article-title":"Sclerosing epithelioid fibrosarcoma: a distinct sarcoma with aggressive features","volume":"45","author":"Warmke","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R2-20260305","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00408-012-9401-0","article-title":"Primary sclerosing epithelioid fibrosarcoma of the lung in a patient with lynch syndrome","volume":"190","author":"Leisibach","year":"2012","journal-title":"Lung"},{"key":"R3-20260305","first-page":"7278","article-title":"18F-fluorodeoxyglucose PET\/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma","volume":"7","author":"Luo","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R4-20260305","first-page":"e50967","article-title":"Response to immunotherapy in sclerosing epithelioid fibrosarcoma: case report and literature review","volume":"15","author":"Koerner","year":"2023","journal-title":"Cureus"},{"key":"R5-20260305","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/RLU.0000000000004757","article-title":"Biodistribution and internal dosimetry of 68 Ga-DOTA-IBA PET imaging for patients with bone metastases","volume":"48","author":"Yang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R6-20260305","doi-asserted-by":"crossref","first-page":"1027792","DOI":"10.3389\/fonc.2022.1027792","article-title":"Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"R7-20260305","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/RLU.0000000000005133","article-title":"68Ga-DOTA-ibandronic acid PET\/CT in a patient with chemotherapy-induced salivary gland hypofunction","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20260305","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/RLU.0000000000005415","article-title":"Incidental uptake of 68Ga-DOTA-IBA in prostate adenocarcinoma","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R10-20260305","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/RLU.0000000000005200","article-title":"68 Ga-DOTA-IBA uptake in breast cancer","volume":"49","author":"Xiang","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R12-20260305","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00000478-199509000-00001","article-title":"Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma","volume":"19","author":"Meis-Kindblom","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R13-20260305","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/RLU.0000000000005573","article-title":"Efficacy and safety of 177Lu-DOTA-IBA in tumor bone metastasis treatment: a prospective clinical trial","volume":"50","author":"Xu","year":"2025","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:02:51Z","timestamp":1772744571000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006315","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"2025-06-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}